undamentalytics Newsletter
Sign in

Alkermes plc. balance sheet

At the end of fiscal 2025, Alkermes plc. had total assets of $2.49bn, total liabilities of $668m and shareholders' equity of $1.82bn. It held $389m in cash against $0 of debt: net cash of $389m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Mar 20102011Mar 20112012Mar 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents———168224181186191267204273338292457291389631
Receivables—2396134152155191234292257275313288332385334459
Inventory—2040465138639390102126150181186183197261
Total current assets—2533395708777557918099839621,1111,0621,1301,4861,4151,9291,581
Goodwill—09393949393939393939383838383593
Total assets—4521,4351,5781,9191,8561,7261,7971,8251,8051,9502,0241,9642,1362,0562,4874,436
Accounts payable—918193237465640544656336646108108
Deferred revenue (current)—373322237867310—
Total current liabilities—4889101131236212291340391438471498520465543652
Short-term debt—03776633333333—027
Long-term debt—0441358349284281278276274272293290288—01,471
Total debt0044436435635028428127927727529629329128901,512
Total liabilities—605815125225415175946547208839129209345916682,571
Shareholders' equity4133928541,0651,3971,3141,2091,2031,1711,0851,0671,1131,0441,2031,4651,8191,865
Net debt (negative = net cash)———197132169979013732−421−167−2−389880
Shares outstanding—96m130m138m148m151m152m154m156m158m159m162m164m167m162m166m168m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ALKS vs HALOALKS vs INSMALKS vs MDGLALKS vs MRNA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Alkermes plc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alkermes plc.